The malaria drug hydroxychloroquine proved worthless in treating patients with severe Covid, federal doctors report.
The antibiotic Azithromycin, however, made a difference in mortality, say doctors working with the the Department of Veterans Affairs, which runs VA hospitals around the nation.
The study was based on treatments of 368 patients, but the work was not fully randomized. Still, the VA's results look quite strong.
The federal study concluded:
The antibiotic Azithromycin, however, made a difference in mortality, say doctors working with the the Department of Veterans Affairs, which runs VA hospitals around the nation.
The study was based on treatments of 368 patients, but the work was not fully randomized. Still, the VA's results look quite strong.
The federal study concluded:
In this study, we found no evidence that use of hydroxychloroquine, either with or without azithromycin, reduced the risk of mechanical ventilation in patients hospitalized with Covid-19. An association of increased overall mortality was identified in patients treated with hydroxychloroquine alone. These findings highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of these drug,
Preprint of federal study
https://web.archive.org/web/20200421213942/https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v1.full.pdf
No comments:
Post a Comment